Other languages United Therapeutics Corporation

Equities

UTHR

US91307C1027

Real-time Estimate Cboe BZX Other stock markets 12:36:25 2024-06-10 pm EDT			5-day change	1st Jan Change
273.8 ^USD	-0.45%		-1.18%	+24.15%

Jun. 03	Liquidia's Yutrepia Launch Cleared as Court Denies Injunction	MT
May. 16	United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Liquidia's Yutrepia Launch Cleared as Court Denies Injunction	Jun. 03
United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing	May. 16
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing	May. 14
United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing	May. 10
United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing	May. 08
United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing	May. 07
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing	May. 06
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing	May. 06
United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing	May. 03
United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell	May. 01
United Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing	Apr. 23
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing	Apr. 19
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing	Apr. 17
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing	Apr. 15
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing	Apr. 11
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing	Apr. 09
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing	Apr. 05
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing	Apr. 04
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension	Apr. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages United Therapeutics Corporation

Equities

UTHR

US91307C1027

Other languages

Filters